Medipee | Updates

By Thomas Prokopp

Medipee in the Finals of the Healthy Hub Initiative


Dear Companists,

As mentioned in the third update, the Healthy Hub contests offers young companies the opportunity to test their solutions in the direct vicinity of statutory health insurance companies.

We are in the finals of the competition and will present our concept in mid-March. A total of 15 finalists were invited to Berlin, of which 5 will be selected. A jury of experts from a variety of departments in the health insurance companies will make the final selection. Keep your fingers crossed for us.


Information about the Healthy Hub Initiative:

Five health insurance companies – BIG direkt gesund, HEK Hanseatische Krankenkasse, IKK Südwest, mhplus Betriebskrankenkasse, and SBK Siemens Betriebskrankenkasse – came together for the Healthy Hub Initiative to pave the way for innovative ideas in the primary health care market.

The Healthy Hub gives founders the chance to test their solutions’ market viability within the health insurance companies’ daily operations.

The insurance companies carry the cover the cost of the products' performance during the test phase. This gives participants the chance to earn money during the test phase.


Healthy Hub Initiative

You can find more information here:


With kind regards,

Your Medipee team


Only registered Companists can comment. Please log in to leave a comment.


Investments in startups and growth companies offer great opportunities, but they are risk investments. In the worst case, the entire investment amount may be lost. Consequently, investments in startups or growth companies are unsuitable for retirement plans. However, there is no obligation to make further contributions. Investors can minimize their risk by diversifying the amount they invest in startups and growth companies and not investing the entire amount in one startup or growth company. Professional investors often follow this strategy because it causes the risk to be distributed among several investments. In this way, successful investments can balance other less successful investments.

The shares of the investors on Companisto are subordinated profit-participating loans (partiarische Nachrangdarlehen). Such loans are shares in a business with similar characteristics as equity. If the company becomes insolvent or is liquidated, the claims of the investors (Companists) – just like those of all other shareholders of the company – will be satisfied from the assets in the insolvency or the assets in liquidation only after the claims of all other external creditors have been satisfied. Thus, Companists are treated like any other shareholder of the company during insolvency or liquidation proceedings.

The company information published on the Companisto website is provided solely by the companies. The projections made by the companies do not guarantee successful development of the company in the future. Consequently, investments in startups and growth companies are suitable only for those investors who can cope with the risk of a total loss of the capital invested. Investors make their own independent investment decisions and bear all risks themselves.

The investments are provided and issued by the individual companies. Companisto is neither the provider nor the issuer of the investments, but solely the internet service platform.

€ 174,200




12.28 %

Share Offered

Please note
The acquisition of this asset involves considerable risks and can lead to the complete loss of the assets used. The expected yield is not guaranteed and may turn out to be lower.
Contact Us
If you have any questions about investing on Companisto, please contact our service team:

Toll-free phone number for investors

0800 - 100 267 0 (DE)
0800 - 100 267(AT / CH)

We are available Monday through Friday between 9 a.m. – 7 p.m.

For companies
Apply for financing Investment Model FAQ for Companies
Investor Support
Please register in order to see the complete profile of Medipee.
Already registered?    Log in